{"name": "Cara Therapeutics",
 "permalink": "cara-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/cara-therapeutics",
 "homepage_url": "http://www.caratherapeutics.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@caratherapeutics.com",
 "phone_number": "203-567-1500",
 "description": "",
 "created_at": "Tue Apr 20 12:18:47 UTC 2010",
 "updated_at": "Mon Nov 01 03:18:02 UTC 2010",
 "overview": "\u003Cp\u003ECara Therapeutics is an emerging biotechnology company focused on developing novel therapeutics to treat human diseases associated with pain and inflammation. Cara possesses both near-term clinical development opportunities combined with proprietary approaches to developing first-in-class novel therapeutics. Cara\u0026#8217;s most advanced patented compound, CR845, is currently undergoing clinical testing for acute pain and pruritis. This best-in-class compound possesses unique analgesic and anti-inflammatory activities appropriate for multiple therapeutic applications. In addition, Cara aims to develop a future pipeline of first-in-class molecules at novel analgesic and anti-inflammatory targets using its proprietary drug screening technology.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       57],
      "assets/images/resized/0008/4286/84286v1-max-150x150.jpg"],
     [[197,
       76],
      "assets/images/resized/0008/4286/84286v1-max-250x250.jpg"],
     [[197,
       76],
      "assets/images/resized/0008/4286/84286v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$38.7M",
 "funding_rounds":
  [{"round_code": "c",
    "source_url": "http://www.thefreelibrary.com/Cara+Therapeutics+Secures+$19+Million+in+Series+C+Financing.-a0155078851",
    "source_description": "Cara Therapeutics Secures $19 Million in Series C Financing.",
    "raised_amount": 19000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 11,
    "funded_day": 28,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "MVM Life Science Partners",
         "permalink": "mvm-life-science-partners",
         "image":
          {"available_sizes":
            [[[112,
               59],
              "assets/images/resized/0006/8440/68440v2-max-150x150.png"],
             [[112,
               59],
              "assets/images/resized/0006/8440/68440v2-max-250x250.png"],
             [[112,
               59],
              "assets/images/resized/0006/8440/68440v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Alta Partners",
         "permalink": "alta-partners",
         "image":
          {"available_sizes":
            [[[150,
               22],
              "assets/images/resized/0003/4978/34978v1-max-150x150.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-250x250.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Ascent Biomedical Ventures",
         "permalink": "ascent-biomedical-ventures",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0004/8024/48024v1-max-150x150.jpg"],
             [[238,
               94],
              "assets/images/resized/0004/8024/48024v1-max-250x250.jpg"],
             [[238,
               94],
              "assets/images/resized/0004/8024/48024v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "d",
    "source_url": "http://www.fiercebiotech.com/story/cara-rounds-15m-post-op-pain-drug/2010-07-21?utm_medium=rss\u0026utm_source=rss",
    "source_description": "Cara rounds up $15M for post-op pain drug  Read more: Cara rounds up $15M for post-op pain drug",
    "raised_amount": 15000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 7,
    "funded_day": 21,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Rho Capital Partners",
         "permalink": "rho-capital-ventures",
         "image":
          {"available_sizes":
            [[[123,
               73],
              "assets/images/resized/0002/8603/28603v5-max-150x150.jpg"],
             [[123,
               73],
              "assets/images/resized/0002/8603/28603v5-max-250x250.jpg"],
             [[123,
               73],
              "assets/images/resized/0002/8603/28603v5-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Alta Partners",
         "permalink": "alta-partners",
         "image":
          {"available_sizes":
            [[[150,
               22],
              "assets/images/resized/0003/4978/34978v1-max-150x150.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-250x250.png"],
             [[168,
               25],
              "assets/images/resized/0003/4978/34978v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Connecticut Innovations",
         "permalink": "connecticut-innovations",
         "image":
          {"available_sizes":
            [[[145,
               83],
              "assets/images/resized/0002/3444/23444v1-max-150x150.jpg"],
             [[145,
               83],
              "assets/images/resized/0002/3444/23444v1-max-250x250.jpg"],
             [[145,
               83],
              "assets/images/resized/0002/3444/23444v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "MVM Life Science Partners",
         "permalink": "mvm-life-science-partners",
         "image":
          {"available_sizes":
            [[[112,
               59],
              "assets/images/resized/0006/8440/68440v2-max-150x150.png"],
             [[112,
               59],
              "assets/images/resized/0006/8440/68440v2-max-250x250.png"],
             [[112,
               59],
              "assets/images/resized/0006/8440/68440v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company":
        {"name": "Mitsubishi Corporation",
         "permalink": "mitsubishi-corporation",
         "image": null},
       "financial_org": null,
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Scottish Widows Investment Partnership",
         "permalink": "scottish-widows-investment-partnership",
         "image":
          {"available_sizes":
            [[[150,
               40],
              "assets/images/resized/0007/9896/79896v1-max-150x150.jpg"],
             [[242,
               65],
              "assets/images/resized/0007/9896/79896v1-max-250x250.jpg"],
             [[242,
               65],
              "assets/images/resized/0007/9896/79896v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Ascent Biomedical Ventures",
         "permalink": "ascent-biomedical-ventures",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0004/8024/48024v1-max-150x150.jpg"],
             [[238,
               94],
              "assets/images/resized/0004/8024/48024v1-max-250x250.jpg"],
             [[238,
               94],
              "assets/images/resized/0004/8024/48024v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Devon Park BioVentures",
         "permalink": "devon-park-bioventures",
         "image":
          {"available_sizes":
            [[[150,
               27],
              "assets/images/resized/0005/8529/58529v1-max-150x150.png"],
             [[250,
               46],
              "assets/images/resized/0005/8529/58529v1-max-250x250.png"],
             [[450,
               83],
              "assets/images/resized/0005/8529/58529v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "",
    "source_description": "EDGAR",
    "raised_amount": 4700000.0,
    "raised_currency_code": "USD",
    "funded_year": 2005,
    "funded_month": 12,
    "funded_day": 21,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Ascent Biomedical Ventures",
         "permalink": "ascent-biomedical-ventures",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0004/8024/48024v1-max-150x150.jpg"],
             [[238,
               94],
              "assets/images/resized/0004/8024/48024v1-max-250x250.jpg"],
             [[238,
               94],
              "assets/images/resized/0004/8024/48024v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Esperante Ventures",
         "permalink": "esperante-ventures",
         "image":
          {"available_sizes":
            [[[150,
               90],
              "assets/images/resized/0008/1082/81082v2-max-150x150.png"],
             [[178,
               107],
              "assets/images/resized/0008/1082/81082v2-max-250x250.png"],
             [[178,
               107],
              "assets/images/resized/0008/1082/81082v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "One Parrott Drive",
    "address2": "",
    "zip_code": "06484",
    "city": "Shelton",
    "state_code": "CT",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        106],
       "assets/images/resized/0008/4287/84287v1-max-150x150.jpg"],
      [[250,
        177],
       "assets/images/resized/0008/4287/84287v1-max-250x250.jpg"],
      [[450,
        319],
       "assets/images/resized/0008/4287/84287v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}